Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Value-Based Agreements On The Cards For UniQure/CSL’s $3.5m Hemophilia B Gene Therapy
On Top Of Up To 30% Discounts
Dec 13 2022
•
By
Ayisha Sharma
Value-Based Agreements Help Parse Out Risks Associated With Expensive Therapies • Source: Shutterstock
More from Drug Pricing
More from Scrip